8-KSecurities & Listing

DEXCOM INC 8-K Report, Unregistered Securities Sale (Feb 24, 2010)

Filed February 24, 2010For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed a Form 8-K on February 24, 2010, to report an unregistered sale of equity securities. The company entered into an agreement to exchange a principal amount of its 4.75% Convertible Senior Notes due 2027 for shares of its common stock. This transaction involved the issuance of 1,298,544 shares of common stock in exchange for $9,750,000 in aggregate principal amount of the Notes. This exchange is significant for investors as it represents a deleveraging event where the company is reducing its outstanding debt by issuing equity. The transaction was conducted under an exemption from registration, specifically Section 3(a)(9) of the Securities Act of 1933, indicating it was a private exchange with an existing noteholder rather than a public offering. The Chief Financial Officer, Jess Roper, signed the filing.

Key Highlights

  • 1DexCom (DXCM) conducted an unregistered sale of equity securities on February 24, 2010.
  • 2The company issued 1,298,544 shares of common stock.
  • 3The shares were issued in exchange for $9,750,000 in aggregate principal amount of 4.75% Convertible Senior Notes due 2027.
  • 4This transaction effectively reduces DexCom's outstanding debt.
  • 5The exchange was exempt from registration under Section 3(a)(9) of the Securities Act of 1933.
  • 6No commissions or remuneration were paid in connection with the exchange.
  • 7The filing was signed by CFO Jess Roper.

Frequently Asked Questions

The primary purpose of this Form 8-K filing was to report an unregistered sale of equity securities. DexCom exchanged its convertible senior notes for shares of its common stock.

DexCom issued 1,298,544 shares of its common stock in exchange for $9,750,000 in aggregate principal amount of its 4.75% Convertible Senior Notes due 2027.

No, this was not a public offering. The exchange was conducted under an exemption from registration (Section 3(a)(9) of the Securities Act of 1933), suggesting it was a private transaction with an existing noteholder.

This exchange represents a deleveraging event for DexCom, as it reduces the company's outstanding debt by converting it into equity. This can improve the company's balance sheet and reduce future interest expenses.